Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: A tissue microarray study

Cancer Research

Volumn 62, Issue 2, 2002, Pages 497-505

  Xie, Wen ^a   Mertens, Joachim C ^a   Reiss, Daniel J ^a   Reiss, Michael ^a   Rimm, David L ^b   Camp, Robert L ^b   Haffty, Bruce G ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; PHOSPHORYLATION; PREGNANCY; PROGNOSIS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0037081179     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Type β transforming growth factor: A bifunctional regulator of cellular growth
2. TGFβ signal transduction
3. Effects of transforming growth factor β on growth of human mammary epithelial cells in culture
4. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1
5. Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation
6. Apoptotic cell death and tissue remodelling during mouse mammary gland involution
7. The role of transforming growth factor-β in breast cancer - A working hypothesis
8. Transforming growth factor-β and breast cancer: Mammary gland development
9. Mammary tumor suppression by transforming growth factor β 1 transgene expression
10. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
11. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7, 12-dimethylbenz-[a]-anthracene
12. Transforming growth factor-β and breast cancer risk in women with mammary epithelial hyperplasia
13. Loss of expression of transforming growth factor β type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas
14. Transforming growth factor-β type I receptor kinase mutant associated with metastatic breast cancer
15. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
16. DPC4 gene in various tumor types
17. Tissue microarrays for high-throughput molecular profiling of tumor specimens
18. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro
19. Transforming growth factor-β inhibits lactogenic hormone induction β-casein expression in HCl 1 mouse mammary epithelial cells
20. A cell line (HBL-100) established from human breast milk
21. BALB and Kirsten Murine Sarcoma viruses alter growth and differentiation of EGF-dependent BALB/c mouse epidermal keratinocytes lines
22. Cultivation of human breast carcinomas
23. Two syngeneic cell lines from human breast tissue: The aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines
24. A human cell line from a pleural effusion derived from a breast carcinoma
25. Establishment and characterization of a cell line of human breast carcinoma origin
26. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
27. Establishment and characterization of three new continuous cell lines derived from human breast carcinomas
28. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain
29. Smad protein expression and activation in transforming growth factor-β refractory human squamous cell carcinoma cells
30. Validation of tissue microarray technology in breast carcinoma
31. Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR
32. Structural alterations of transforming growth factor-β receptor genes in cervical carcinoma
33. Nonparametric estimation from incomplete observation
34. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbors SV40 genetic information
35. Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines
36. Functional characterization of transforming growth factor β type II receptor mutants in human cancer
37. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
38. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation
39. Inhibiting mutations in the transforming growth factor β type 2 receptor in recurrent human breast cancer
40. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
41. A transforming growth factor β type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability
42. Mutational inactivation of transforming growth factor β receptor type II in microsatellite stable colon cancers
43. Transforming growth factor β I in ductal carcinoma in situ and invasive carcinomas of the breast
44. Localization of transforming growth factor-β isotypes in lesions of the human breast
45. Immunocytochemical localization of secreted transforming growth factor-β I to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma
46. Immunohistochemical staining for transforming growth factor β I associates with disease progression in human breast cancer
47. Latency and activation in the control of TGF-β
48. Latency, activation, and binding proteins of TGF-β
49. Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells
50. Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: Evidence for a secretion into cystic fluid
51. Transforming growth factor β receptor II (TGF-β-RII) is infrequently expressed in human breast cancer
52. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops
53. Expression and secretion of TGF-β isoforms and expression of TGF-β-receptors I, II, and III in normal and neoplastic human breast
54. Expression of transforming growth factor-β receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells
55. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
56. Expression profile of agonistic Smads in human breast cancer cells: Absence of regulation by estrogens
57. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer
58. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumor cells
59. Characterization of functional domains within Smad4/DPC4
60. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways
61. Transforming growth factor-β responsiveness in DPC4/SMAD4-null cancer cells
62. Dpc4 transcriptional activation and dysfunction in cancer cells
63. Overexpression of human cyclin D1 reduces the transforming growth factor β (TGF-β) type II receptor and growth inhibition by TGF-β I in an immortalized human esophageal epithelial cell line
64. Cyclin D1 protein expression and function in human breast cancer
65. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining
66. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program
67. Molecular predictors of survival after adjuvant chemotherapy for colon cancer